Cargando…
Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Future Medicine Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246498/ https://www.ncbi.nlm.nih.gov/pubmed/34249141 http://dx.doi.org/10.2217/fvl-2021-0072 |
| _version_ | 1783716325662654464 |
|---|---|
| author | Chebel, Roy Labaki, Chris Farhat, Maria Kattan, Joseph |
| author_facet | Chebel, Roy Labaki, Chris Farhat, Maria Kattan, Joseph |
| author_sort | Chebel, Roy |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8246498 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Future Medicine Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82464982021-07-07 Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer Chebel, Roy Labaki, Chris Farhat, Maria Kattan, Joseph Future Virol Editorial Future Medicine Ltd 2021-06-30 2021-06 /pmc/articles/PMC8246498/ /pubmed/34249141 http://dx.doi.org/10.2217/fvl-2021-0072 Text en © 2021 Future Medicine Ltd |
| spellingShingle | Editorial Chebel, Roy Labaki, Chris Farhat, Maria Kattan, Joseph Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer |
| title | Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer |
| title_full | Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer |
| title_fullStr | Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer |
| title_full_unstemmed | Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer |
| title_short | Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer |
| title_sort | safety, efficacy and acceptability of sars-cov-2 vaccines in patients with cancer |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246498/ https://www.ncbi.nlm.nih.gov/pubmed/34249141 http://dx.doi.org/10.2217/fvl-2021-0072 |
| work_keys_str_mv | AT chebelroy safetyefficacyandacceptabilityofsarscov2vaccinesinpatientswithcancer AT labakichris safetyefficacyandacceptabilityofsarscov2vaccinesinpatientswithcancer AT farhatmaria safetyefficacyandacceptabilityofsarscov2vaccinesinpatientswithcancer AT kattanjoseph safetyefficacyandacceptabilityofsarscov2vaccinesinpatientswithcancer |